Interferonâ•’alphaâ•’2aâ•’Injektionen bei ausgedehnten multiplen planen Virusakanthomen als
möglicher neuer Th Page 1 Correspondence Clinical Letter 514 © 2022 The Authors. Journal …

Due to the tedious and stressful clinical course, weekly subcutaneous abdominal
administration of 3 million IU of interferon alpha-2a (RoferonA®) was initiated at the Stuttgart …

To the Editor: The etiology of Kaposi sarcoma (KS) was uncertain until the discovery of a
new herpes virus, designated KS-associated herpes virus or human herpes virus 8 (HHV8) …

A 52-year-old woman was seen for erythematous papules and plaques that developed 6
weeks after initiation of a combined Peg-IFN-ribavirine therapy for hepatitis C virus (HCV) …

Background: Spontaneous involution of giant keratoacanthomas (KAs) can leave large scars
or cause mutilation. Human papillomaviruses have recently been demonstrated in KAs …

We observed the efficacy and toxicity of recombinant human interferon-orA (rHu IFN-arA) in
the treatment of classic Kaposi's sarcoma. The patient, who was a 60-year-old male, was …

BACKGROUND: Complete excision is not always easy when a keratoacanthoma is large or
located in certain anatomic areas. An effective nonsurgical treatment would be desirable in …

Background: Kaposi's sarcoma (KS) is the most common neoplasm in patients with acquired
immunodeficiency syndrome (AIDS). To date, no therapy has proved to be consistently …

The objective of this non-controlled interventional clinical study was to evaluate the efficacy
of imiquimod in the treatment of fields with multiple, multiform AK. 180 office-based …

Abstract IPA COPYRIGHT: ASHP The successful treatment of keratoacanthomas with topical
alpha-interferon applied 4 times daily under occlusive dressing in 5 kidney transplant …